The reelection of former President Donald Trump initially pleased investors who had worried about another protracted legal ...
Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for priority review the supplemental biologics license application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback